Literature DB >> 30289820

Dysbiosis in Snoring Children: An Interlink to Comorbidities?

Maria Carmen Collado1,2, Maija Kristiina Katila3,4, Nina Maria Vuorela5, Outi Saarenpää-Heikkilä3,4, Seppo Salminen2, Erika Isolauri6.   

Abstract

BACKGROUND AND OBJECTIVES: Early microbial colonization has a key impact on infant health through nutritional, immunological, and metabolic programming. The origin of child snoring is multifactorial and complex, and may thereby also generate long-term health problems. The link between child snoring and gut microbes remains unclear, although indirect evidence exists regarding this relationship. This study aimed to characterize the connection between gut microbiota and child snoring.
METHODS: In a prospective, observational CHILD-SLEEP birth cohort study, gut microbiota in a subcohort of 43 of these children at 2 years of life was profiled with 16S ribosomal RNA gene amplicon sequencing.
RESULTS: A higher abundance of the Proteobacteria phylum, the Enterobacteriaceae family, and Erysipelotrichaceae family, as well as a higher ratio of Firmicutes to Bacteroidetes were detected in snorers as compared to controls. Furthermore, snorers showed significantly lower microbial diversity and richness than non-snorers.
CONCLUSIONS: The snoring children manifest different gut microbiota as compared with healthy children. Considering that snoring and sleep disorders can be a source of long-term consequences, including cardiovascular, metabolic, immunological, neurocognitive and behavioral consequences, our results proposes early microbiota as a new treatment target.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30289820     DOI: 10.1097/MPG.0000000000002161

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  5 in total

1.  Obstructive Sleep Apnea and Systemic Hypertension: Gut Dysbiosis as the Mediator?

Authors:  Saif Mashaqi; David Gozal
Journal:  J Clin Sleep Med       Date:  2019-10-15       Impact factor: 4.062

Review 2.  Obstructive Sleep Apnea as a Risk Factor for COVID-19 Severity-The Gut Microbiome as a Common Player Mediating Systemic Inflammation via Gut Barrier Dysfunction.

Authors:  Saif Mashaqi; Rekha Kallamadi; Abhishek Matta; Stuart F Quan; Salma I Patel; Daniel Combs; Lauren Estep; Joyce Lee-Iannotti; Charles Smith; Sairam Parthasarathy; David Gozal
Journal:  Cells       Date:  2022-05-06       Impact factor: 7.666

Review 3.  The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea.

Authors:  Mohammad Badran; Saif Mashaqi; David Gozal
Journal:  Expert Opin Ther Targets       Date:  2020-12-04       Impact factor: 6.797

4.  Characteristics of salivary microbiota in children with obstructive sleep apnea: A prospective study with polysomnography.

Authors:  Xin Huang; Xuehui Chen; Xu Gong; Ying Xu; Zhifei Xu; Xuemei Gao
Journal:  Front Cell Infect Microbiol       Date:  2022-08-29       Impact factor: 6.073

Review 5.  Role of Recent Therapeutic Applications and the Infection Strategies of Shiga Toxin-Producing Escherichia coli.

Authors:  Su-Bin Hwang; Ramachandran Chelliah; Ji Eun Kang; Momna Rubab; Eric Banan-MwineDaliri; Fazle Elahi; Deog-Hwan Oh
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.